Bioinformatics Analysis of Stem Cell circ-ASB3 Signaling Pathway and Its Affection on Glioma Biological Characteristics

• Published in: Frontiers in neuroinformatics Vol. 16; p. 859937
• Main Authors: Guowei, Li, Yanping, Jin
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Research Foundation 12.04.2022; Frontiers Media S.A
• Subjects: Apoptosis; axis; Bioinformatics; bioinformatics analysis; Cell cycle; Cell migration; Cell proliferation; circRNA; Flow cytometry; Genes; Glioma cells; glioma stem cell (GSC); Malignancy; Medical research; Metastasis; miRNA; mRNA; Neuroscience; Polymerase chain reaction; Signal transduction; Software; Stem cells; Therapeutic targets; Transfection; Tumors; Beijing China; United States > US; China; circRNA; malignancy; axis; bioinformatics analysis; glioma stem cell (GSC)
• ISSN: 1662-5196; 1662-5196
• DOI: 10.3389/fninf.2022.859937

In our research we try to explore whether glioma stem cell containing circRNAs signal pathway could regulate glioma malignant progression and elaborate its possible mechanism. In this study, we used biological information analysis to build an RNA regulatory network and then proceeded RT-PCR to screen target RNAs, after that we clarified the targeting relationship between circRNA-miRNA-mRNA through double luciferase gene assay, RNA pull down experiment, PCR and Western Blot. Finally we adopted RNA transfection to identify its impact on glioma cell proliferation, invasion, migration, apoptosis and cell cycle. circ-ASB3 was significantly up-regulated in glioma stem cells compared with glioma cells. The circ-ASB3/miR-543/Twist1 axis was discovered to be a possible regulatory pathway in glioma, circ-ASB3 could adsorb and targeted bind to miR-543, down-regulate miR-543 expression, thus release its targeted inhibition to Twist1. Circ-ASB3 was shown to increase glioma cell proliferation, invasion, and migration miR-543/Twist1 axis. Meanwhile glioma cell apoptosis could be inhibited, and cell cycle arrest could be induced through this signaling pathway. circ-ASB3 could enhance glioma malignancy miR-543/Twist1 axis, resulting in the discovery of new biomarkers and possible therapeutic targets for these patients.